SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending amid a sharp intraday reversal, prompting discussions about potential market manipulation and the strength of the AI sector following Nvidia's earnings; traders are actively debating whether this pullback represents a buying opportunity or the start of a deeper correction, with some pointing to possible Yen carry trade issues.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is experiencing volatility, sparking debates about a potential market bottom and the influence of large institutional players. Community discussions revolve around whether this dip presents a buying opportunity or signals a deeper correction, with some pointing to macro factors and potential liquidations as drivers. Sentiment is mixed, with bullish and bearish arguments clashing amidst the price swings.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia's stock is trending amid upgrades from analysts, though some community members express concern over valuation relative to competitors and potential interconnect hurdles in the AI sector. Despite strong earnings, the stock experienced a selloff, leading to discussions about a possible short squeeze and whether AI constitutes a bubble.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is experiencing heavy volatility, sparking discussions about a potential market correction and whether dip-buying strategies will continue to pay off. Some community members are pointing to broader macroeconomic concerns and the influence of crypto markets, while others are eyeing key support levels for potential reversals. The conversation highlights uncertainty around near-term market direction.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is trending due to strong Q3 earnings and raised FY26 guidance, sparking bullish sentiment among investors; discussions include the impact of e-commerce growth and a planned move to the Nasdaq. Community members are debating whether Walmart's performance signals broader economic strength or if it's a safe haven during market uncertainty, while also pondering its valuation relative to tech companies.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending downwards, frustrating investors who cite strong deliveries and question the stock's valuation relative to peers. Community members speculate about market manipulation and potential short squeezes while bracing for upcoming earnings. Despite the negative price action, some investors remain optimistic, viewing the current dip as a buying opportunity based on the company's long-term potential.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Strategy is trending as the price of Bitcoin fluctuates, impacting MicroStrategy's value as a major BTC holder; the community is closely watching key support levels. Discussions revolve around analyst Tom Lee's commentary and potential short squeezes, with some expressing concerns about solvency and potential liquidation. Recent whale activity and overall market sentiment add to the volatility.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares

SOXL is trending as traders assess its volatile movements amidst optimism in the AI sector. Community discussions revolve around dip-buying strategies and potential profit-taking points, especially with upcoming earnings from key semiconductor players like NVDA. The ongoing government shutdown and concerns about AI valuations add to the uncertainty surrounding this leveraged ETF.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is trending following a target price increase from UBS and rising memory prices linked to AI data-center demand, fueling discussions about its growth potential. Community members are weighing the bullish outlook against concerns of an overbought condition after the stock's significant year-to-date gains. Discussions also focus on potential short-term pullbacks versus long-term opportunities in the semiconductor space.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending amidst overall crypto market volatility and the launch of new ETFs, sparking debates on their potential impact. Community discussions revolve around whether XRP can decouple from Bitcoin's influence and the significance of upcoming ISO20022 compliance. Some traders express frustration with price stagnation, while others remain optimistic about long-term utility and institutional adoption.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Retail investors on Stocktwits are optimistic about Genius Group’s pivot and hope to see the same returns as MicroStrategy after the latter pivoted to a Bitcoin-first strategy in 2020. | Source: Pixabay

Why Is Genius Group Stock Rising Today?

Genius Group repurchased its stock on the open market at an average price of $0.90 per share from August 28 to September 11, 2025.

Equity

Global Equity ETFs Draw Rising Investor Interest

Global equity funds saw $10.65B inflows as Fed rate cut bets, a weak dollar and diversification needs drive investors abroad.

U.S.-listed shares of Birkenstock Holding were up 3% in premarket trading on Thursday, ahead of the German footwear company's quarterly report before the market opens.Analysts expect its third-quarter revenue to rise 19.3%, similar to the preceding two quarters, according to Kofin data. Investors&nbsp;will be watching for comments on the impact of tariffs, price hikes, supply chain disruptions, and the demand landscape in North America and Europe.Piper Sandler, which reaffirmed its 'Overweight' rating this week, noted that unfavorable foreign exchange rates could pressure the company's reported revenue.Birkenstock, known for its clogs or sandals, is in a notably good position. In May, the company raised its annual profit outlook and authorized a $200 million share buyback. Still,&nbsp;<a href="https://stocktwits.com/symbol/BIRK">BIRK shares</a> are down 11% year-to-date.The stock has gained nearly 6% in the last two sessions, and the latest retail sentiment reading on Stocktwits is ‘extremely bullish,’ signaling investor optimism.<figure class="image"><img style="aspect-ratio:629/72;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_14_at_2_38_43_PM_png_0145047a9b.webp" alt="Screenshot 2025-08-14 at 2.38.43 PM.png" width="629" height="72"><figcaption>BIRK sentiment and message volume as of August 14 | Source: Stocktwits</figcaption></figure>Late last month, Goldman Sachs&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/birkenstock-scores-buy-rating-from-goldman-sachs-shares-rise/choGriXR5vX">raised</a> its rating on Birkenstock to ‘Buy’ from ‘Neutral,’ citing "robust" momentum and an attractive valuation for the company's shares in a challenging&nbsp;macroeconomic backdrop.Footwear companies face broad pressure from U.S. import tariffs on major Asian manufacturing hubs, including China and Vietnam.Swiss company On Holding posted strong quarterly sales and raised its full-year target,&nbsp;attributing the increase to recent price increases on its shoes. In the future, CEO Martin Hoffmann&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/on-holding-ceo-martin-hoffmann-says-the-sportswear-maker-is-in-a-good-position-to-digest-tariffs/chrCS0bRd9p">told</a> Stocktwits that the company is now "in a very good position to digest" the tariffs.Birkenstock also raised prices in the U.S. last month.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Various Birkenstock shoes are displayed on shelves in a Birkenstock store on Ehrenstraße. Photo: Rolf Vennenbernd/dpa (Photo by Rolf Vennenbernd/picture alliance via Getty Images)

Why Are Birkenstock Shares Rising Premarket?

The move shows optimism ahead of the German footwear company's quarterly report.

Birkenstock Holding (BIRK) shares rose over 1.5% in Thursday's session and another 2% in extended trading, after Goldman Sachs raised its rating on the sandal maker.The research firm raised the rating on the company's shares to 'Buy' from 'Neutral,' while maintaining its $60 price target, according to a summary of the investor note on The Fly. That indicates an over 15% upside to BIRK's last closing price.Currently, 20 of the 22 analysts covering the stock have a 'Buy' or higher rating, and two rate it 'Hold,' according to Koyfin data. Their average price target is $72.26.Goldman Sachs sees "robust" momentum and an attractive valuation for Birkenstock in a challenging macro backdrop. The company has a "strong" product proposition, with pricing power and opportunities to win share in a "highly fragmented" footwear market, the research firm said.Goldman Sachs also noted Birkenstock's vertically integrated manufacturing setup in Europe, which would support the company's margins.Although&nbsp;<a href="https://stocktwits.com/symbol/BIRK">BIRK shares</a> have rebounded over the last couple of weeks, they remain 15.5% below their 2025 peak achieved on Jan. 30.On Stocktwits, retail sentiment shifted to 'neutral' early Friday from 'bearish' the previous day, with several users&nbsp;taking note of the latest upgrade.<figure class="image"><img style="aspect-ratio:1416/154;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_25_at_10_41_26_AM_png_d52d1b15f5.webp" alt="Screenshot 2025-07-25 at 10.41.26 AM.png" width="1416" height="154"><figcaption>BIRK sentiment and message volume as of July 25 | Source: Stocktwits</figcaption></figure>In May, Birkenstock raised its annual profit outlook and authorized a&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/birkenstock-authorizes-200m-buyback-but-retail-remains-cold/ch0AkaLRbti">$200 million share buyback</a>.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/chinese-e-commerce-giant-jd-com-could-reportedly-snap-up-media-markt-parent-for-2-6-b-retail-bulls-eye-breakout/choGqh1R5v9">Chinese E-Commerce Giant JD.com Could Reportedly Snap Up MediaMarkt Parent For $2.6B: Retail Bulls Eye Breakout</a>

A Birkenstock shoe displayed on in a Birkenstock store in North Rhine-Westphalia, Cologne, Germany. (Photo by Rolf Vennenbernd/picture alliance via Getty Images)

Birkenstock Scores 'Buy' Rating From Goldman Sachs, Shares Rise 

The sandal maker has "robust" momentum, attractive valuation, and pricing power, the research firm says.

German sandal&nbsp;maker Birkenstock has filed an infringement lawsuit in India's capital, New Delhi, against four footwear traders, four factories, and two unnamed individuals following a company investigation revealed the production, sale, and export of counterfeit products, according to a Reuters report.The&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/sustainability/boards-policy-regulation/birkenstock-cracks-down-fakes-india-court-ordered-factory-visits-held-sources-2025-07-06/">report</a>, which cites people familiar with the matter,&nbsp;comes as the footwear industry is garnering increased attention in India. Earlier this month, Crocs (CROX) secured a court nod to pursue a nine-year-old infringement case. At the same time,&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/prada-credits-centuries-old-indian-kolhapuri-craftsmanship-behind-open-toe-sandals-design-unveiled-at-milan-show/chmZe7GRReZ">Prada drew criticism</a> after its sandals at a Milan showcase looked nearly identical to Indian Khandasari chappals, prompting the Italian fashion brand to acknowledge the similarity.According to the report, Birkenstock filed the lawsuit in the Delhi High Court in May. It claims that Birkenstock counterfeits were being manufactured in rural areas near the North Indian tourist hub of Agra and sold both locally and exported to other countries. The court has ordered law enforcement inspections of these facilities.India is a key market for the German brand, which last month opened its 50th standalone store in the country,&nbsp;in the financial capital of Mumbai.On Stocktwits, the retail sentiment for BIRK remained 'bullish,' unchanged from a week ago.&nbsp;<a href="https://stocktwits.com/symbol/BIRK">Birkenstock shares</a> are down nearly 14% year-to-date.<figure class="image"><img style="aspect-ratio:615/69;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_07_at_2_06_14_PM_png_bdebef4034.webp" alt="Screenshot 2025-07-07 at 2.06.14 PM.png" width="615" height="69"><figcaption>BIRK sentiment and message volume as of July 7 | Source: Stocktwits</figcaption></figure>The development comes at a time of strength for the company. It recently reported strong results for its fiscal second quarter,&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/birkenstock-raises-annual-profit-forecast-shares-retail-sentiment-surge/chivoCURbnc">raised its annual profit forecast</a>, and authorized a&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/birkenstock-authorizes-200m-buyback-but-retail-remains-cold/ch0AkaLRbti">$200 million buyback</a>.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Birkenstock Reportedly Sues Indian Footwear Makers Over Counterfeits Amid Rising Industry Scrutiny

India is a key market for the German brand, which last month opened its 50th standalone store in the country.

Nasdaq-listed shares of argenx SE (ARGX) rose 2% by Friday afternoon after the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://argenx.com/news/2024/argenx-announces-european-commission-approval-of-vyvgart--efgart">announced</a> that the European Commission approved its VYVGART 1,000 mg subcutaneous (SC) injection in the treatment of adult patients with progressive or relapsing active chronic inflammatory demyelinating polyneuropathy (CIDP).CIDP is a rare and often progressive autoimmune disease of the peripheral nervous system. Patients with CIPD experience a range of mobility and sensory issues, including trouble standing from a seated position, pain and fatigue, and frequent tripping or falling.The European Commission approved the subcutaneous injection as a monotherapy for patients with the disease who have received prior treatment with corticosteroids or immunoglobulins.The EC approval will apply to all 27 European Union Member States, as well as to Iceland, Liechtenstein, and Norway.VYVGART for SC injection is available as a vial or prefilled syringe and can be administered by a patient, caregiver, or healthcare professional. The company stated that it is “working closely” with local regulatory authorities to ensure patients can access the treatment as soon as possible.The approval is based on a clinical trial that demonstrated 66.5% of patients treated with VYVGART SC showed evidence of clinical improvement, including improvements in mobility, function, and strength. The study also revealed a 61% reduction in the risk of relapse compared to the placebo.This regulatory approval marks the second for VYVGART SC in Europe, which first received approval as an add-on to standard therapy for the treatment of adult patients with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive.On Stocktwits, retail sentiment around argenx remained within ‘bullish’ territory over the past 24 hours while message volume remained ‘normal’.<figure class="image"><img style="aspect-ratio:631/68;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_20_at_2_09_51_PM_png_2b09c4d552.webp" alt="ARGX's Sentiment Meter and Message Volume as of 2:10 p.m. ET on June 20, 2025 | Source: Stocktwits" width="631" height="68"><figcaption>ARGX's Sentiment Meter and Message Volume as of 2:10 p.m. ET on June 20, 2025 | Source: Stocktwits</figcaption></figure> <a href="https://stocktwits.com/symbol/ARGX">ARGX stock</a> is down by 12% this year but has gained over 40% in the past 12 months.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/meta-considered-perplexity-acquisition-before-14-3-b-scale-ai-deal/chlxqohRRPz">Meta Reportedly Considered Perplexity Acquisition Before $14.3B Scale AI Deal</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration an argenx SE logo seen displayed on a smartphone. (Photo Illustration by Igor Golovniov/SOPA Images/LightRocket via Getty Images)

Argenx Gets European Commission Approval For Drug To Treat Rare Autoimmune Disease, But Stock Fails To Garner Retail Attention

VYVGART for SC injection is available in vials or prefilled syringes and can be administered by a patient, caregiver, or healthcare professional.

U.K.-based biopharmaceutical company GSK plc (GSK) <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.gsk.com/en-gb/media/press-releases/gsk-s-rsv-vaccine-arexvy-accepted-for-regulatory-review-by-the-european-medicines-agency-to-expand-use-in-adults-18-years-and-older/">said</a> on Friday that the European Medicines Agency (EMA) has accepted its regulatory application to expand the use of its adjuvanted recombinant respiratory syncytial virus (RSV) vaccine to include adults aged 18 years or above.Arexvy is already approved in the European Economic Area for the prevention of lower respiratory tract disease (LRTD) caused by RSV in adults aged 60 and older, and for those aged 50-59 years who are at increased risk for RSV disease due to underlying medical conditions.RSV is a common contagious virus affecting the lungs and breathing passages and impacts an estimated 64 million people of all ages globally every year, GSK said. The virus can aggravate conditions such as asthma and chronic heart failure, leading to hospitalisation and death.The company is looking forward to a decision from the regulator on the application in the first half of 2026.Meanwhile, the firm is continuing to seek an expansion for the treatment scope of its RSV vaccine in geographies including the U.S. and Japan.Arexvy brought in 78 million British pounds ($106.08 million) for GSK in the first quarter of 2025, down 57% from the corresponding period of 2024, following a drop in sales in the U.S., and accounting for just 1% of its overall turnover in the period.On Stocktwits, retail sentiment around GSK remained unmoved within ‘extremely bearish’ territory over the past 24 hours while message volume remained unchanged at ‘normal’ levels.<figure class="image"><img style="aspect-ratio:1258/126;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_13_at_12_12_04_PM_png_f36e4b25b0.webp" alt="GSK's Sentiment Meter and Message Volume as of 12:15 p.m. ET on Jun 13, 2025 | Source: Stocktwits" width="1258" height="126"><figcaption>GSK's Sentiment Meter and Message Volume as of 12:15 p.m. ET on Jun 13, 2025 | Source: Stocktwits</figcaption></figure>NYSE-listed shares of GSK are down by 3% as of Friday noon. <a href="https://stocktwits.com/symbol/GSK">The stock</a> is up approximately 22% this year and has increased by about 1% over the past 12 months.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/urogen-price-target-upgrade-after-fda-approval-for-cancer-medicine/chli4GKRRbJ">UroGen Soars On Price Target Upgrade On Heels Of FDA Approval For Cancer Medicine: Retail Sees Stock Touching $20</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the logo of GSK plc is displayed on a smartphone screen, on April 26, 2025, in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images)

GSK’s Application To European Authorities For Expanded Use Of RSV Vaccine In Younger Adults Fails To Rejuvenate Retail Optimism

The company is looking forward to a decision from the regulator on the application in the first half of 2026.

Brookfield Asset Management (BAM) has announced a potential investment of up to SEK 95 billion (approximately $10 billion) to develop AI infrastructure in Sweden, marking one of its largest AI initiatives in Europe to date.The funding will be directed toward developing a large-scale AI center in Strängnäs, forming a key component of Sweden’s digital infrastructure aligned with its national AI goals.&nbsp;The facility is expected to grow its capacity from 300 megawatts (MW) to 750 MW, supported by a land deal encompassing around 350,000 square meters.Brookfield expects the Strängnäs facility to create over 1,000 permanent positions, with another 2,000 jobs expected during the 10- to 15-year construction phase.&nbsp;“To compete in the development of AI and realize its economic productivity, it is important to invest at scale in the infrastructure underpinning this technology,” said&nbsp;Head of Europe, Brookfield, Sikander Rashid.According to a Reuters report, the growing adoption of AI and regulations mandating data storage within Europe have sparked a surge in data center development across the region.&nbsp;Companies like Microsoft Inc. (MSFT), Meta Platforms Inc.(META), and Alphabet Inc. (GOOG, GOOGL) have selected Sweden for their facilities, drawn by the country's dependable power supply, infrastructure, and strong connectivity.&nbsp;Brookfield’s AI infrastructure includes more than €100 billion ($114 billion) allocated to areas such as digital connectivity, clean energy, and semiconductor ventures worldwide.&nbsp;In early 2024, the company introduced a €20 billion investment program in France, which features a €10 billion commitment to the country’s inaugural AI manufacturing facility.&nbsp;&nbsp;&nbsp;The New York-based global alternative asset manager oversees over $1 trillion in assets, focusing on long-term investments in real assets and essential service sectors.On Stocktwits, retail sentiment around Brookfield remained in ‘bearish’ territory.<figure class="image"><img style="aspect-ratio:644/74;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_04_083036_png_932e692b08.webp" alt="BAM's Sentiment Meter and Message Volume as of 08:30 a.m. ET on June 4, 2025 | Source: Stocktwits" width="644" height="74"><figcaption>BAM's Sentiment Meter and Message Volume as of 08:30 a.m. ET on June 4, 2025 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/BAM">Brookfield</a> stock has gained over 4% year-to-date and over 44% in the last 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/crowdstrike-stock-slumps-post-q1-print-as-analysts-turn-cautious/chkuff6RbwY">CrowdStrike Stock Slumps Post Q1 Print As Analysts Turn Cautious: Retail Seizes Pullback Opportunity</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.Exchange Rate: 1SEK = 0.10 USD1EUR = 1.14 USD

In this photo illustration, the logo of Brookfield Corporation is displayed on a smartphone screen on April 26, 2025, in Chongqing, China.

Brookfield Commits $10B To Sweden’s AI Expansion: Retail Sees No Reason To Cheer

The AI center in Strängnäs, Sweden, will expand capacity to 750 MW and create 3,000 jobs in the coming years.

German sandals&nbsp;maker Birkenstock Holding (BIRK)&nbsp;said on Wednesday that it plans to buy back $200 million worth of company shares and&nbsp;announced the sale of a block of shares by one of its investors.BK LC Lux MidCo, an entity affiliated with private equity firm L Catterton, is selling 15.7 million shares of Birkenstock at $52.50 a piece. That totals to over $824 million.The shares are being offered to public investors through underwriters in a secondary public offering.Meanwhile, Birkenstock has authorized a $200 million buyback&nbsp;by purchasing an estimated 3.7 million shares. The company's repurchase depends on the progress of the sale by BK LC Lux.Goldman Sachs and JPMorgan are acting as joint book-running managers for the offering.The move comes at a time of strength for the German shoe brand. Earlier this month, Birkenstock reported strong results for the last quarter and raised its annual profit forecast.Revenue rose by a higher-than-expected 19% for its fiscal second quarter, while net profit grew 68%.Birkenstock’s recent performance&nbsp;contrasts with that of other shoe brands, including Nike (NKE) and Crocs, which are grappling with uneven consumer demand following President Donald Trump’s tariff announcements last month.On Stocktwits, the retail sentiment was 'bearish,' unchanged from a month ago.<figure class="image"><img style="aspect-ratio:1276/146;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_29_at_2_30_55_PM_png_e313452594.webp" alt="Screenshot 2025-05-29 at 2.30.55 PM.png" width="1276" height="146"><figcaption>BIRK sentiment and message volume as of May 28 | Source: Stocktwits</figcaption></figure>Birkenstock was listed on the New York Stock Exchange in October 2023.Its shares are down 4.2%% year to date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Birkenstock Authorizes $200M Buyback, But Retail Remains Cold

One of the company's investors is selling over $800 million worth of shares in a secondary market offering.

Shares of Merus N.V. (MRUS) rocketed 32% on Friday morning after the stock witnessed price target hikes on the heels of the company announcing positive data from one of its ongoing drug trials.Oncology company Merus on Thursday <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.merus.nl/news-releases/news-release-details/merus-petosemtamab-pembrolizumab-interim-data-demonstrates">said</a> that the combination of bispecific antibody Petosemtamab with Pembrolizumab demonstrated robust efficacy and durability in its ongoing phase 2 trial as of Feb. 27.Merus CEO Bill Lundberg said the data from the trial demonstrates that Petosemtamab in combination with Pembrolizumab can become “a new standard of care" in head and neck cancer and is “significantly better” than treatment with just Pembrolizumab.The company said that as of Feb. 27, 45 patients had been treated in the phase 2 trial, and the combination was generally well tolerated.The CEO also expressed optimism about sharing data from one or both of its late-stage combination trials in 2026.BofA on Friday hiked the price target on Merus to $92 from $70 while keeping a ‘Buy’ rating on the shares. The firm noted that the recently announced data set the combination as "the best-in-class treatment option for this patient population."The analyst’s new price target implies a 121% upside to Merus’s closing share price of $41.6 on Thursday.BMO Capital also hiked the price target on Merus to $110 from $96 on Friday while keeping an ‘Outperform’ rating on the shares. BMO said it sees a 90% probability of the combination's approval for treating head and neck cancer.On Stocktwits, retail sentiment around Merus jumped from ‘bearish’ to ‘extremely bullish’ territory over the past 24 hours while message volume jumped from ‘normal’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:626/63;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_23_at_10_48_55_AM_png_3d759215e6.webp" alt="MRUS's Sentiment Meter and Message Volume as of 10:50 a.m. ET on May 23, 2025 | Source: Stocktwits" width="626" height="63"><figcaption>MRUS's Sentiment Meter and Message Volume as of 10:50 a.m. ET on May 23, 2025 | Source: Stocktwits</figcaption></figure> <a href="https://stocktwits.com/symbol/MRUS">MRUS stock</a> is up by about 30% this year and 25% over the past 12 months.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/jp-morgan-bank-of-america-citigroup-wells-fargo-reportedly-explore-joint-stablecoin/ch0QZ5vRbqs">JPMorgan, Bank of America, Citigroup, Wells Fargo Reportedly Explore Joint Stablecoin</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Merus Stock Soars On Positive Phase 2 Drug Trial Data, Price Target Hikes: Retail’s Thrilled

BofA’s new price target of $92 implies a 121% upside to Merus’s closing share price of $41.6 on Thursday.

SPDW
SPDR Portfolio Developed World ex-US ETF

Feed

News

Sentiment

Fundamentals

Info

Latest SPDW News

SPDWSPDR Portfolio Developed World ex-US ETF